Literature DB >> 16715255

Ventral hippocampal alpha7 and alpha4beta2 nicotinic receptor blockade and clozapine effects on memory in female rats.

Ana Pocivavsek1, Laura Icenogle, Edward D Levin.   

Abstract

RATIONALE: Nicotinic systems in the hippocampus play important roles in memory function. Decreased hippocampal nicotinic receptor concentration is associated with cognitive impairment in schizophrenia and Alzheimer's disease.
METHODS: We modeled in rats the cognitive effects of chronic decrease in hippocampal alpha7 or alpha4beta2 receptors with 4-week continuous bilateral local infusions of the alpha7 nicotinic antagonist methyllycaconitine (MLA) or the alpha4beta2 antagonist dihydro-beta-erythroidine (DHbetaE). The working memory effects of these infusions were assessed by performance on the radial-arm maze. To test the effect of antipsychotic medication, we gave acute injections of clozapine and to determine the impact of nicotine, which is widely used by people with schizophrenia approximately half of the rats received chronic systemic infusions of nicotine.
RESULTS: Chronic ventral hippocampal DHbetaE infusion caused a significant (p < 0.001) working memory impairment. Acute systemic clozapine (2.5 mg/kg) caused a significant (p < 0.005) working memory impairment in rats given control aCSF hippocampal infusions. Clozapine significantly (p < 0.025) attenuated the memory deficit caused by chronic hippocampal DHbetaE infusions. Chronic ventral hippocampal infusions with MLA did not significantly affect the working memory performance in the radial-arm maze, but it did significantly (p < 0.05) potentiate the memory impairment caused by 1.25 mg/kg of clozapine. Chronic systemic nicotine did not significantly interact with these effects.
CONCLUSIONS: The state of nicotinic receptor activation in the ventral hippocampus significantly affected the impact of clozapine on working memory with blockade of alpha7 nicotinic receptors potentiating clozapine-induced memory impairment and blockade of alpha4beta2 receptors reversing the clozapine effect from impairing to improving memory.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16715255      PMCID: PMC1847383          DOI: 10.1007/s00213-006-0416-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  35 in total

1.  Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum.

Authors:  Michele Zoli; Milena Moretti; Alessio Zanardi; J Michael McIntosh; Francesco Clementi; Cecilia Gotti
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

Review 2.  Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.

Authors:  P A Newhouse; A Potter; E D Levin
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

3.  Ventral hippocampal alpha 7 nicotinic receptor blockade and chronic nicotine effects on memory performance in the radial-arm maze.

Authors:  J H Bettany; E D Levin
Journal:  Pharmacol Biochem Behav       Date:  2001-12       Impact factor: 3.533

4.  Nicotine interactions with haloperidol, clozapine and risperidone and working memory function in rats.

Authors:  Nii Addy; Edward D Levin
Journal:  Neuropsychopharmacology       Date:  2002-10       Impact factor: 7.853

5.  Ventral hippocampal alpha4beta2 nicotinic receptors and chronic nicotine effects on memory.

Authors:  A Bancroft; E D Levin
Journal:  Neuropharmacology       Date:  2000-10       Impact factor: 5.250

6.  Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory.

Authors:  E D Levin; A Bradley; N Addy; N Sigurani
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

7.  Chronic inhibition of alpha4beta2 nicotinic receptors in the ventral hippocampus of rats: impacts on memory and nicotine response.

Authors:  David Arthur; Edward D Levin
Journal:  Psychopharmacology (Berl)       Date:  2001-12-20       Impact factor: 4.530

8.  Inhibition of nicotinic acetylcholine receptors and calcium channels by clozapine in bovine adrenal chromaffin cells.

Authors:  T Park; S Bae; S Choi; B Kang; K Kim
Journal:  Biochem Pharmacol       Date:  2001-04-15       Impact factor: 5.858

9.  Nicotine-antipsychotic drug interactions and attentional performance in female rats.

Authors:  Amir H Rezvani; Edward D Levin
Journal:  Eur J Pharmacol       Date:  2004-02-20       Impact factor: 4.432

10.  Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases.

Authors:  E K Perry; R H Perry; C J Smith; D J Dick; J M Candy; J A Edwardson; A Fairbairn; G Blessed
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-06       Impact factor: 10.154

View more
  15 in total

1.  Nicotine improves working memory span capacity in rats following sub-chronic ketamine exposure.

Authors:  Samantha L Rushforth; Thomas Steckler; Mohammed Shoaib
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

Review 2.  Classifying antipsychotic agents : need for new terminology.

Authors:  Ripu D Jindal; Matcheri S Keshavan
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 3.  Targeting neuronal dysfunction in schizophrenia with nicotine: Evidence from neurophysiology to neuroimaging.

Authors:  Jason Smucny; Jason R Tregellas
Journal:  J Psychopharmacol       Date:  2017-04-26       Impact factor: 4.153

4.  Decreasing nicotinic receptor activity and the spatial learning impairment caused by the NMDA glutamate antagonist dizocilpine in rats.

Authors:  Dennis A Burke; Pooneh Heshmati; Ehsan Kholdebarin; Edward D Levin
Journal:  Eur J Pharmacol       Date:  2014-07-24       Impact factor: 4.432

5.  PPI deficit induced by amphetamine is attenuated by the histamine H1 antagonist pyrilamine, but is exacerbated by the serotonin 5-HT2 antagonist ketanserin.

Authors:  José A Larrauri; Edward D Levin
Journal:  Psychopharmacology (Berl)       Date:  2010-09-02       Impact factor: 4.530

6.  Histamine H1 receptor involvement in prepulse inhibition and memory function: relevance for the antipsychotic actions of clozapine.

Authors:  Cindy S Roegge; Charles Perraut; Xin Hao; Edward D Levin
Journal:  Pharmacol Biochem Behav       Date:  2007-02-22       Impact factor: 3.533

7.  Single photon emission computed tomography experience with (S)-5-[(123)I]iodo-3-(2-azetidinylmethoxy)pyridine in the living human brain of smokers and nonsmokers.

Authors:  James Robert Brasić; Yun Zhou; John L Musachio; John Hilton; Hong Fan; Andrew Crabb; Christopher J Endres; Melvin J Reinhardt; Ahmet S Dogan; Mohab Alexander; Olivier Rousset; Marika A Maris; Jeffrey Galecki; Ayon Nandi; Dean F Wong
Journal:  Synapse       Date:  2009-04       Impact factor: 2.562

8.  Chronic underactivity of medial frontal cortical beta2-containing nicotinic receptors increases clozapine-induced working memory impairment in female rats.

Authors:  Edward D Levin; Abigail Perkins; Terrell Brotherton; Melissa Qazi; Chantal Berez; Janitza Montalvo-Ortiz; Kasey Davis; Paul Williams; N Channelle Christopher
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-12-24       Impact factor: 5.067

9.  Atypical antipsychotics as noncompetitive inhibitors of alpha4beta2 and alpha7 neuronal nicotinic receptors.

Authors:  Vladimir P Grinevich; Roger L Papke; Patrick M Lippiello; Merouane Bencherif
Journal:  Neuropharmacology       Date:  2009-05-28       Impact factor: 5.250

Review 10.  Complex relationships of nicotinic receptor actions and cognitive functions.

Authors:  Edward D Levin
Journal:  Biochem Pharmacol       Date:  2013-08-06       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.